Christian Larsen, United States
Selective Implementation of Belatacept Every Other Month as Standard Care Option with Use of cfDNA Testing

Alex Rogers, United States
A Donor Derived Cell Free DNA Approach to Immunosuppression Minimization in Elderly Kidney Transplant Recipients

Elizabeth Hendren, Canada
A Matched Cohort Analysis of Kidney Transplant Recipients Treated with Depleting and Non-Depleting Antibody Induction and Early Corticosteroid Cessation

Marta Crespo, Spain
Pretransplant Response to Immunosuppressants Measured with Immunobiogram Predicts First-Year Rejection in Kidney Transplant Recipients

Alex Zendel, United States
De Novo Belatacept Maintenance Immunosuppression Protocol as a Strategy to Increase Utilization of Kidney Allografts - 5-Year Experience

Zahraa Khan, United States
HLA-Epitope Mismatches and De Novo Donor Specific Antibodies (dDSA) Development Post-BK Virus Nephropathy

Guillaume Onyeaghala, United States
Gut Microbiome Meta-Transcriptomics Associated with Mycophenolate Mofetil Enterohepatic Recirculation in Kidney Transplant Recipients

Daniel Schuster, United States
Subcutaneous Administration of a CD28 Co-Stimulation Blocker Demonstrates Efficacy in an NHP Model of Kidney Allotransplantation